XML 41 R28.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2022
Stock-Based Compensation  
Schedule of stock-based compensation expense

Stock-based compensation expense as reflected in the Company’s condensed consolidated statements of operations and comprehensive loss was as follows (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three months ended
September 30, 

​

Nine months ended
September 30, 

​

    

2022

    

2021

​

2022

    

2021

Research and development

​

$

211

​

$

83

​

$

485

​

$

157

General and administrative

​

 

672

​

 

576

​

 

1,862

​

 

725

Stock-based compensation expense included in operating expenses

​

$

883

​

$

659

​

$

2,347

​

$

882

Summary of stock option activity

The following is a summary of the Company’s stock option activity for the nine months ended September 30, 2022:

​

​

​

​

​

​

​

​

​

​

​

​

    

​

    

Weighted- 

    

Weighted- average 

    

Aggregate 

​

​

​

​

average 

​

remaining contractual 

​

intrinsic value

​

​

Options

​

exercise price

​

term (in years)

​

(in thousands)

Outstanding at December 31, 2021

 

3,021,799

​

$

3.71

 

8.94

​

$

10,903

Granted

 

1,628,795

​

 

3.06

 

​

​

 

​

Exercised

​

(44,105)

​

​

0.43

​

​

​

​

​

Cancelled

​

(232,987)

​

​

4.24

​

​

​

​

​

Outstanding at September 30, 2022

 

4,373,502

​

 

3.47

 

8.86

​

$

477

Vested at September 30, 2022

 

1,189,491

​

 

1.95

 

8.66

​

$

316

Vested and expected to vest at September 30, 2022

 

4,373,502

​

$

3.47

 

8.86

​

$

477

​

The following is a summary of the Company’s stock option activity for the nine months ended September 30, 2021:

​

​

​

​

​

​

​

​

​

​

​

​

    

​

    

Weighted- 

    

Weighted- average 

    

Aggregate 

​

​

​

​

average 

​

remaining contractual 

​

intrinsic value

​

​

Options

​

exercise price

​

term ( in years)

​

(in thousands)

Outstanding at December 31, 2020

 

1,761,062

​

$

0.95

 

9.54

​

$

723

Granted

 

1,088,000

​

 

7.78

 

—

​

 

3,087

Outstanding at September 30, 2021

 

2,849,062

​

 

3.56

 

9.13

​

$

12,056

Vested at September 30, 2021

 

398,157

​

 

0.96

 

8.30

​

$

2,805

Vested and expected to vest at September 30, 2021

 

2,849,062

​

$

3.56

 

9.13

​

$

12,056

Schedule of assumptions used in estimation of fair value

The weighted average grant-date fair value of stock options granted during the nine months ended September 30, 2022 and 2021 was $2.04 and $5.07 per share, respectively. The fair value of each stock option was estimated using a Black-Scholes option-pricing model with the following assumptions:

​

​

​

​

​

​

​

​

​

​

​

​

    

Three months ended September 30, 

 

​

Nine months ended September 30, 

 

​

​

2022

    

2021

 

​

2022

    

2021

 

Risk-free interest rate

 

2.71 - 3.47

%  

1.19

%

​

1.62 - 3.47

%  

0.95 - 1.19

%

Volatility

 

72

%  

76

%

​

72 - 80

%  

76 - 77

%

Dividend yield

 

0.00

%  

0.00

%

​

0.00

%  

0.00

%

Expected term (years)

 

6

 

6

​

​

6

 

6

​

Summary of restricted stock units activity

The following table summarizes activity related to RSUs:

​

​

​

​

​

​

​

    

​

    

Weighted- average

​

​

​

​

grant date

​

​

Number of shares

​

fair value

Unvested at December 31, 2021

 

200,996

​

$

16.00

Granted

 

—

​

 

—

Vested

​

(62,811)

​

$

16.00

Unvested at September 30, 2022

 

138,185

​

$

16.00